![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, February 23, 2011 12:47:03 PM
IMHO, it should be filed this quarter but we will still have to wait for approval which may continue to drag on.
The re-file will not really move the PPS much (if at all) but if/when the FDA approves it then we should see movement.
"will the Co issue a PR when refiled?"
I believe that they will...
"what type of bumpin pps we'll see upon refiling?"
Not much if you ask me. The first real bump should be approval of the 510K by the FDA and IMHO the real bump will be the partnership announcement once it is approved.
I see CXM milestones as the following:
1) Approval of 510K
2) Announcement of Partnership for the marketing and distribution once it is approved.
3) Revenue from sales
The things I like about CXM is the potential for a partnership (and/or buy-out) and the chance for some real ongoing revenue by mid 2012 and that right now their share structure is still pretty decent.
The downside is that I do expect some dilution soon as their cash starts running lower. I am personally o.k. with this if it is done in a responsible way but from a market stand-point it will push it to under $0.20 if I had to guess. I'm ready to buy when/if it does but that is a risk that I am willing to take.
Like all Bio's it is risky so do your own DD.
I am playing this for a long term (2012-2013) share price of $10 plus..
GLTA
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM